Michael D. Witzeman - 21 Oct 2025 Form 4 Insider Report for CHEMED CORP (CHE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
22 Oct 2025, 16:19:31 UTC
Prior SEC filing
11 Mar 2025
Next SEC filing
17 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Michael D. Witzeman

Key filing fact

Michael D. Witzeman filed Form 4 for CHEMED CORP (CHE) on 22 Oct 2025.

Key facts

  • This page summarizes Michael D. Witzeman's Form 4 filing for CHEMED CORP (CHE).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 22 Oct 2025, 16:19.

Change

  • Previous filing in this sequence was filed on 11 Mar 2025.
  • Current net transaction value: +$8,647,692.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001699624 Primary reporting owner

Witzeman Michael D

Relationship
VP & Chief Financial Officer
Address
2600 CHEMED CENTER, 255 EAST FIFTH STREET, CINCINNATI
Signature
Michael D. Witzeman
Signature date
22 Oct 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CHE transaction Derivative

Stock Option (right to buy with tandem tax withholding)

Award

Transaction value
$8,647,692
Shares
+19,486
Change %
+57%
Price
$443.79
Shares after
53,970
Date
21 Oct 2025
Ownership
Direct
Underlying class
Capital Stock
Underlying amount
19,486
Exercise price
$443.79
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Vesting in three equal annual installments commencing 10/21/2026

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .